Latest Trials

Systemic therapy trial

APROC : A phase1b/2 Study Evaluating the Efficacy of APR-246, a First-in-class Agent Targeting...

This phase Ib/II trial is trying to determine whether the drug APR-246 and two chemotherapy drugs (5-FU and cisplatin) are safe and effective in the treatment of platinum resistant oesophageal cancer

Status : Recruiting

Radiotherapy trial

EXPERT : A Randomised Phase III Trial of Adjuvant Radiation Therapy Versus Observation Following...

This phase III trial is examining personalised radiation therapy for low-risk early breast cancer

Status : Recruiting

Systemic therapy trial

A Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Anti-tumor Activity of...

This Phase I trial is evaluating an intravenous drug (ABBV-321) in patients with advanced cancers that are associated with EGFR overexpression

Status : Recruiting

Systemic therapy trial

SYMPATICO : Phase 3 Study of Ibrutinib in Combination With Venetoclax in Subjects With Mantle Cell...

This phase III trial is combining two oral drugs (Ibrutinib and Venetoclax) for the treatment of Mantle Cell Lymphoma

Status : Recruiting

Systemic therapy trial

PEARLS : A Randomized, Phase 3 Trial With Anti-PD-1 Monoclonal Antibody Pembrolizumab (MK-3475)...

This phase III trial is evaluating an immunotherapy drug (Pembrolizumab) as an additional therapy in patients with Non Small Cell (NSC) Lung Cancer following surgery and the completion of a standard adjuvant therapy

Status : Recruiting

Systemic therapy trial

PLIMATH : A Multi-centre Phase II Study to Determine the Response Kinetics, Safety and Efficacy of...

This Phase II trial is evaluating the drug pembrolizumab (commonly used in immunotherapy) as a treatment for patients with newly diagnosed Hodkgin Lymphoma

Status : Recruiting

Multiple treatment types

SABRseq : Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade...

This Phase Ib trial is evaluating the safety and effect of giving pembrolizumab (commonly used as an immunotherapy drug), to patients with metastatic non-small cell (NSC) lung cancer, before or after radiotherapy treatment

Status : Recruiting

Systemic therapy trial

A Phase 1b Study of Talimogene Laherparepvec in Combination With Atezolizumab in Subjects...

This phase 1b trial is combining two different biological injections (a talimogene laherparepvec injection into the liver and an atezolizumab injection into the vein) in patients who have triple negative breast cancer or colorectal cancer that has spread to the liver

Status : Recruiting

Systemic therapy trial

A Randomized, Double-Blind, Placebo Controlled Phase 3 Study of Venetoclax in Combination...

This phase III trial is trying to determine whether adding venetoclax (an oral drug) to azacitidine treatment works better than azacitidine treatment on its own in patients with newly diagnosed Acute Myeloid Leukaemia (AML)

Status : Recruiting

Systemic therapy trial

VIP : Phase II Study of Intravenous Vinorelbine in Patients With Relapsed Platinum Resistant or...

This phase II trial is evaluating an intravenous drug (Vinorelbine) for the treatment of recurrent C5 high grade serous, endometrioid, or undifferentiated primary peritoneum, fallopian tube or ovarian cancer

Status : Recruiting

 

Looking for a trial? Use the search functionality to find the trial you are finding.